Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's potential to treat many of the most common types of cancer. Here is an overview of the data coming out of today's session:
Multiple Tumor Types:
Stomach & Gastrointestinal Cancer:
Come back for more updates from tomorrow's presentations.
June is Cancer Immunotherapy Month
Read Previous Article
ASCO17: Day 3 Immunotherapy Highlights
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Dr. Ansuman Satpathy is building a single-cell atlas to help us better understand why immunotherapy succeeds or fails in certain patients.
While many are adjusting to virtual fundraisers at the moment, the Epic Film Guys now have plenty of experience, running their fourth fundraiser May 27-31, 2020.